Balyasny Asset Management’s NextGen Healthcare, Inc. Common Stock NXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-644,881
Closed -$15.3M 3032
2023
Q3
$15.3M Buy
644,881
+550,412
+583% +$10.4M 0.03% 685
2023
Q2
$1.53M Buy
94,469
+12,183
+15% +$202K ﹤0.01% 1466
2023
Q1
$1.43M Buy
82,286
+79,250
+2,610% +$1.42M ﹤0.01% 1601
2022
Q4
$57K Buy
+3,036
New +$58.5K ﹤0.01% 2331
2022
Q2
Sell
-11,776
Closed -$246K 3308
2022
Q1
$246K Sell
11,776
-360,478
-97% -$6.9M ﹤0.01% 1978
2021
Q4
$6.62M Buy
+372,254
New +$5.98M 0.02% 758
2018
Q1
Sell
-22,922
Closed -$311K 2413
2017
Q4
$311K Sell
22,922
-97
-0.4% -$1.39K ﹤0.01% 1726
2017
Q3
$362K Buy
+23,019
New +$372K ﹤0.01% 1450
2017
Q2
Sell
-15,984
Closed -$244K 1828
2017
Q1
$244K Buy
+15,984
New +$235K ﹤0.01% 1444
2016
Q1
Sell
-62,510
Closed -$1.01M 1585
2015
Q4
$1.01M Sell
62,510
-186,183
-75% -$2.72M 0.01% 711
2015
Q3
$3.1M Sell
248,693
-448,054
-64% -$6.15M 0.02% 606
2015
Q2
$11.5M Sell
696,747
-377,786
-35% -$6.09M 0.07% 358
2015
Q1
$17.2M Sell
1,074,533
-229,314
-18% -$3.79M 0.14% 226
2014
Q4
$20.3M Buy
1,303,847
+182,686
+16% +$2.67M 0.19% 163
2014
Q3
$15.4M Buy
1,121,161
+279,091
+33% +$4.23M 0.12% 214
2014
Q2
$13.5M Buy
842,070
+409,342
+95% +$6.47M 0.15% 166
2014
Q1
$7.3M Buy
432,728
+107,307
+33% +$1.95M 0.08% 298
2013
Q4
$6.85M Sell
325,421
-211,363
-39% -$4.76M 0.09% 263
2013
Q3
$11.7M Buy
+536,784
New +$11.5M 0.16% 174

Other funds holding NXGN

Balyasny Asset Management's NXGN Position: Q4 2023 in Review

Balyasny Asset Management sold out of NextGen Healthcare, Inc. Common Stock (NXGN) in Q4 2023, closing a stake of 644,881 shares — an estimated $15.3M sold.

Balyasny Asset Management first reported a position in NXGN in Q3 2013 and held it in 19 quarters. The position peaked at $20.3M in Q4 2014. 1 fund tracked by Wall St. Rank holds NXGN as of Q4 2023.

  • Balyasny Asset Management reported no remaining NextGen Healthcare, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Balyasny Asset Management sold 644,881 NextGen Healthcare, Inc. Common Stock shares in Q4 2023, an estimated $15.3M.
  • Balyasny Asset Management first reported a position in NextGen Healthcare, Inc. Common Stock in Q3 2013 and held it in 19 quarters.
  • Balyasny Asset Management's NextGen Healthcare, Inc. Common Stock position peaked at $20.3M in Q4 2014.
  • 1 fund tracked by Wall St. Rank held NextGen Healthcare, Inc. Common Stock as of Q4 2023.

Based on Balyasny Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.